Insights
Fifteen+ years of
healthcare thinking.
Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
ESSENTIAL READING
Amazon becomes a shopping facilitator for healthcare services (finally…)
- By Tory Wolff
Back in 2018, I offered a speculation about what Amazon might do in he…
Read more
Some very disappointing failures: An opinionated take on NEJM highlights for August and September 2022
- By Marc Herant
- NEJM
Is Parkinson’s α-synuclein going to be as elusive a target as β-amyloi…
Read more
Trends in oncolytic virus therapeutics: then and now
- By David Kaufmann and Marc Herant
- Biopharma
PDF: Trends in oncolytic virus therapeutics: then and now
The idea of …
Read more
Are some of Kaiser’s regional ambitions starting to pay off?
- By Jacob Wiesenthal and Tory Wolff
- Payers ,
- Providers
PDF: Are some of Kaiser’s regional ambitions starting to pay off?
We h…
Read more
What should school nurses do (and not do)? A call for further research
- By Alyssa Idusuyi
- Providers
About the author: Alyssa Idusuyi is currently a high school senior att…
Read more
An auto- or allo- future for cell therapy?
- By Sarah Dolman and Maggie Pickard
- Biopharma
Download a PDF of this article here.
Ex vivo gene-therapies have been …
Read more
An innovative sales strategy for a pivotal drug; Novartis trailblazes with Leqvio
- By Thomas Uhler and Jason Brauner
- Biopharma
After the $9.7B acquisition of The Medicines Company two and a half ye…
Read more
An excellent July vintage: an opinionated take on NEJM highlights for July 2022
- By Marc Herant
- NEJM
Tirzepatide in pole position
As previously described in this blog, GLP…
Read more
What’s so special about One Medical in the eyes of Amazon? A few quick thoughts
- By Tory Wolff and Thomas Uhler
- Providers ,
- Digital ,
There isn’t a bricks-and-mortar primary care acquisition out there tha…
Read more
SELECTED ENGAGEMENTS
Insight, put to work
Our published thinking is one half of the picture. These are representative client engagements, anonymized — each tagged by sector, so you can trace the path from perspective to practice.
- Institutional
Strategy for Statewide Health Information Exchange
A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable
HIE, Health IT,
- Medtech, Early Stage
Growth strategy for point-of-care testing
Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform
Growth, product market fit, value proposition
- Institutional
University Trials
Large university wanting to dramatically increase its clinical research footprint
Keep up with Recon Strategy Insights
Get an email each time we publish a new article